EIB grants Elekta over SEK 1.1 billion loan for new cancer treatments
Medical technology company Elekta is receiving a loan of just over SEK 1.1 billion from the European Investment Bank (EIB) to develop new cancer treatments.
BusinessMedical technology company Elekta is receiving a loan of just over SEK 1.1 billion from the European Investment Bank (EIB) to develop new cancer treatments.
BusinessQuick efforts are required to get Europe's major defense investments in place. But a warning about the debts, Sweden cautions.
BusinessThe EU is getting ready for a massive buildup to manage without the USA and Donald Trump. More is to be expected when old rules are adapted to reality.
World